Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C17H24F2N6O |
| Molecular Weight | 366.4089 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1(F)CCN(C1)C(=O)[C@@H]2C[C@@H](CN2)N3CCN(CC3)C4=NC=CC=N4
InChI
InChIKey=QWEWGXUTRTXFRF-KBPBESRZSA-N
InChI=1S/C17H24F2N6O/c18-17(19)2-5-25(12-17)15(26)14-10-13(11-22-14)23-6-8-24(9-7-23)16-20-3-1-4-21-16/h1,3-4,13-14,22H,2,5-12H2/t13-,14-/m0/s1
Gosogliptin (PF-734200) is a compound developed for treatment of type II diabetes and has been approved for use in Russia. It is a selective dipeptidyl peptidase 4 (DPP-4) inhibitor, with hypoglycemic activity. The drug is safe and well tolerated at all doses tested when added to metformin (a diabetes drug), and safely and effectively lowered HbA (1c) in subjects receiving metformin. A phase 3 study to study the safety and efficacy of gosogliptin has been completed. Gosogliptin has also been studied as potential drug for the treatment of renal insufficiency.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The pharmacokinetics of PF-734200, a DPP-IV inhibitor, in subjects with renal insufficiency. | 2011-07 |
|
| (3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitor. | 2009-04-01 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C98086
Created by
admin on Mon Mar 31 18:50:54 GMT 2025 , Edited by admin on Mon Mar 31 18:50:54 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
GI718UO477
Created by
admin on Mon Mar 31 18:50:54 GMT 2025 , Edited by admin on Mon Mar 31 18:50:54 GMT 2025
|
PRIMARY | |||
|
9148
Created by
admin on Mon Mar 31 18:50:54 GMT 2025 , Edited by admin on Mon Mar 31 18:50:54 GMT 2025
|
PRIMARY | |||
|
UU-151
Created by
admin on Mon Mar 31 18:50:54 GMT 2025 , Edited by admin on Mon Mar 31 18:50:54 GMT 2025
|
PRIMARY | |||
|
300000034154
Created by
admin on Mon Mar 31 18:50:54 GMT 2025 , Edited by admin on Mon Mar 31 18:50:54 GMT 2025
|
PRIMARY | |||
|
869490-23-3
Created by
admin on Mon Mar 31 18:50:54 GMT 2025 , Edited by admin on Mon Mar 31 18:50:54 GMT 2025
|
PRIMARY | |||
|
CHEMBL515387
Created by
admin on Mon Mar 31 18:50:54 GMT 2025 , Edited by admin on Mon Mar 31 18:50:54 GMT 2025
|
PRIMARY | |||
|
DTXSID601007213
Created by
admin on Mon Mar 31 18:50:54 GMT 2025 , Edited by admin on Mon Mar 31 18:50:54 GMT 2025
|
PRIMARY | |||
|
11516136
Created by
admin on Mon Mar 31 18:50:54 GMT 2025 , Edited by admin on Mon Mar 31 18:50:54 GMT 2025
|
PRIMARY | |||
|
Gosogliptin
Created by
admin on Mon Mar 31 18:50:54 GMT 2025 , Edited by admin on Mon Mar 31 18:50:54 GMT 2025
|
PRIMARY | |||
|
DB08382
Created by
admin on Mon Mar 31 18:50:54 GMT 2025 , Edited by admin on Mon Mar 31 18:50:54 GMT 2025
|
PRIMARY | |||
|
C90616
Created by
admin on Mon Mar 31 18:50:54 GMT 2025 , Edited by admin on Mon Mar 31 18:50:54 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
